Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,210,050 papers from all fields of science
Search
Sign In
Create Free Account
Indinavir:MCnc:Pt:Ser/Plas:Qn
Known as:
Indinavir:MKnz:Pkt:Ser/Plas:Qn
, Indinavir:Concentration de masse:Temps ponctuel:Sérum/Plasma:Quantitatif
, Indinavir:????:????:??/??:??
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Indinavir
Plas
Serum
Unit of Mass Concentration
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Liquid chromatography tandem mass spectrometric studies of indinavir sulphate and its forced degradation products.
R. Rao
,
R. M. Vali
,
S. Raju
Journal of Pharmaceutical and Biomedical Analysis
2013
Corpus ID: 12424328
2008
2008
Pharmacokinetics of an Indinavir‐Ritonavir‐Fosamprenavir Regimen in Patients with Human Immunodeficiency Virus
I. Ofotokun
,
E. Acosta
,
J. Lennox
,
Yi Pan
,
Kirk A Easley
Pharmacotherapy
2008
Corpus ID: 3370031
Study Objective. To evaluate the pharmacokinetic compatibility of a ritonavir‐boosted indinavir‐fosamprenavir combination among…
Expand
2006
2006
Low urine pH is associated with reduced indinavir crystalluria in indinavir-treated HIV-infected individuals.
R. Gagnon
,
A. Alli
,
M. Edwardes
,
A. K. Watters
,
C. Tsoukas
Clinical Nephrology
2006
Corpus ID: 12560665
Indinavir is a potent HIV-1 protease inhibitor included in current antiretroviral therapeutic regimens. It is associated with…
Expand
2004
2004
The ICH guidance in practice: stress degradation studies on indinavir sulphate and development of a validated specific stability-indicating HPTLC assay method.
N. Kaul
,
H. Agrawal
,
A. Paradkar
,
K. Mahadik
Il Farmaco
2004
Corpus ID: 8451478
2004
2004
Indinavir-Urolithiasis bei HIV-positiven Patienten
Christos Kalaitzis
,
S. Touloupidis
,
E. Patris
,
K. Lehrich
,
R. Kuntz
Der Urologe, Ausgabe A
2004
Corpus ID: 35814357
ZusammenfassungZielsetzungIndinavirsulfat (Crixivan®) ist ein Proteaseinhibitor, der seit 1996 erfolgreich bei der Behandlung HIV…
Expand
2002
2002
Litiasis ureteral por Indinavir: Report of one case
F. GonzaloValero
,
N. RodrigoLeyton
,
A. AntonioValenzuela
2002
Corpus ID: 71331588
We report a 27 years old male, treated with Indinavir as a prophylactic anti-HIV agent, who consulted for left ureteral pain…
Expand
2000
2000
CÓLICO RENAL Y LITIASIS EN PACIENTES HIV (+) TRATADOS CON INHIBIDORES DE PROTEASAS
C. Enguita
,
I. J. Jiménez
,
J. Pérez
,
R. Rubio
,
M. J. gil
,
R. V. Navarrete
2000
Corpus ID: 70493402
2000
2000
Indinavir Crystalluria in an HIV-Positive Man
D. Hachey
,
R. Force
,
J. Schott
,
Erin O'Leary-Jepsen
The Annals of Pharmacotherapy
2000
Corpus ID: 30396619
1998
1998
Indinavir crystalluria: identification of patients at increased risk of developing nephrotoxicity.
L. D. Trainor
,
J. Steinberg
,
G. Austin
,
H. M. Solomon
Archives of Pathology & Laboratory Medicine
1998
Corpus ID: 24918526
OBJECTIVE To determine whether the protease inhibitor indinavir sulfate, which is extremely insoluble at physiologic pH levels…
Expand
Review
1997
Review
1997
[Influence of foods on the absorption of antimicrobial agents].
M. F. Fraga Fuentes
,
B. García Díaz
,
P. de Juana Velasco
,
M. B. Bermejo Vicedo
Nutrición Hospitalaria
1997
Corpus ID: 2076248
Understanding the interaction between foods and antimicrobial agents is an aspect of therapy which may have an important clinical…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE